Journal Summary - Discover more summaries and articles from M3 India - Oncology

Profile

Close

Journal Summaries

Oncology

Pharmacology/Therapy

Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer

New England Journal of Medicine | Feb 25, 2019 Pharmacology/Therapy

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): Disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Oncology | Feb 25, 2019 Pharmacology/Therapy

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: Revisiting the results of the EORTC-STBSG 62931 randomised trial

European Journal of Cancer | Feb 25, 2019 Pharmacology/Therapy

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: The MOMA trial

European Journal of Cancer | Feb 25, 2019 Pharmacology/Therapy

Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—A randomised multicentre trial (ASTER trial). An ANOCEF study

European Journal of Cancer | Feb 25, 2019 Pharmacology/Therapy

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Lung Cancer | Feb 25, 2019 Pharmacology/Therapy

Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity

Journal of the American College of Cardiology | Feb 23, 2019 Pharmacology/Therapy

Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery

British Journal of Surgery | Feb 22, 2019 Pharmacology/Therapy

Safety and efficacy of durvalumab with or without tremelimumab in patients with PD-L1–low/negative recurrent or metastatic HNSCC: The phase 2 CONDOR randomized clinical trial

JAMA | Feb 21, 2019 Pharmacology/Therapy

Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy: Three-year follow-up of a randomized phase 3 trial

JAMA | Feb 21, 2019 Pharmacology/Therapy

« Prev 1 … 233 234 235 236 237 … 375 Next »

Most read this week

Home
Quiz
Videos
Menu

Add M3 India to your Home screen

Tap

and select "Add to Home screen" to pin the M3 India App to your Home screen

Okay